Thibault V, Bélanger M, LeBlanc E, Babin L, Halpine S, Greene B et al (2016) Factors that could

explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a

critical review and analysis. Diabetol Metab Syndr 8:71

Tölle TR (2010) Challenges with current treatment of neuropathic pain. Eur J Pain Suppl 4:161–165

Trivedi S, Pandit A, Ganguly G, Das S (2017) Epidemiology of peripheral neuropathy: an Indian

perspective. Ann Indian Acad Neurol 20(3):173–184

Tsuda M, Tozaki-Saitoh H, Inoue K (2010) Pain and purinergic signaling. Brain Res Rev 63:222–

232

Viswanathan V, Seena R, Nair MB, Snehalatha C, Bhoopathy RM, Ramachandran A (2004) Nerve

conduction abnormalities in different stages of glucose intolerance. Neurol India 52:466–469

Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW, Gong DJ et al (2010) Intrathecal siRNA against

toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci 7(5):

251–259

Wu F, Pan R, Chen J, Sugita M, Chen C, Tao Y et al (2014) Lentivirus mediated siRNA against

GluN2B subunit of NMDA receptor reduces nociception in a rat model of neuropathic pain.

Biomed Res Int 2014:871637

Xiong W, Huang L, Shen Y, Guan S, He L, Tong Z et al (2017) Effects of lncRNA uc.48+ siRNA

on the release of CGRP in the spinal cords of rats with diabetic neuropathic pain. Int J Clin Exp

Pathol 10(9):9960–9969

Xu GY, Li G, Liu N, Huang LYM (2011) Mechanisms underlying purinergic P2X3 receptor-

mediated mechanical allodynia induced in diabetic rats. Mol Pain 7:60

Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH (1993) A multicentre study of

the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic popula-

tion. Diabetologia 36(2):150–154

Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB (2013) STAT6 siRNA matrix-

loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using

adenocarcinoma cells. Biomed Res Int 2013:858946

Zhang A, Gao Y, Zhong X, Xu C, Li G, Liu S et al (2010) Effect of sodium ferulate on the

hyperalgesia mediated by P2X3 receptor in the neuropathic pain rats. Brain Res:215–221

Zhang P, An K, Duan X, Xu H, Li F, Xu F (2018) Recent advances in siRNA delivery for cancer

therapy using smart nanocarriers. Drug Discov Today 23:900–911

Zhao J, Feng SS (2015) Nanocarriers for delivery of siRNA and co-delivery of siRNA and other

therapeutic agents. Nanomedicine 10:2199–2228

Zhou HY, Chen SR, Pan HL (2011) Targeting N-methyl-D-aspartate receptors for treatment of

neuropathic pain. Expert Rev Clin Pharmacol 4:379–388

Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A (2009) Neuropathic pain in diabetes,

prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg surveys S2 and S3.

Pain Med 10:393–400

Zin CS, Nissen LM, Smith MT, O’Callaghan JP, Moore BJ (2008) An update on the pharmacolog-

ical management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 22:

417–442

20

siRNA-Encapsulated Nanoparticles for Targeting Dorsal Root Ganglion (DRG). . .

385